Glenmark Pharmaceuticals Ltd
NSE:GLENMARK
Intrinsic Value
The intrinsic value of one GLENMARK stock under the Base Case scenario is 1 009.74 INR. Compared to the current market price of 1 515.45 INR, Glenmark Pharmaceuticals Ltd is Overvalued by 33%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Glenmark Pharmaceuticals Ltd
Fundamental Analysis

Revenue & Expenses Breakdown
Glenmark Pharmaceuticals Ltd
Balance Sheet Decomposition
Glenmark Pharmaceuticals Ltd
Current Assets | 90.3B |
Cash & Short-Term Investments | 20.4B |
Receivables | 28.6B |
Other Current Assets | 41.3B |
Non-Current Assets | 62B |
Long-Term Investments | 1.1B |
PP&E | 35.5B |
Intangibles | 13.5B |
Other Non-Current Assets | 11.9B |
Free Cash Flow Analysis
Glenmark Pharmaceuticals Ltd
INR | |
Free Cash Flow | INR |
Earnings Waterfall
Glenmark Pharmaceuticals Ltd
Revenue
|
122.5B
INR
|
Cost of Revenue
|
-42.1B
INR
|
Gross Profit
|
80.4B
INR
|
Operating Expenses
|
-70.9B
INR
|
Operating Income
|
9.5B
INR
|
Other Expenses
|
-18.2B
INR
|
Net Income
|
-8.8B
INR
|
GLENMARK Profitability Score
Profitability Due Diligence
Glenmark Pharmaceuticals Ltd's profitability score is 37/100. The higher the profitability score, the more profitable the company is.
Score
Glenmark Pharmaceuticals Ltd's profitability score is 37/100. The higher the profitability score, the more profitable the company is.
GLENMARK Solvency Score
Solvency Due Diligence
Glenmark Pharmaceuticals Ltd's solvency score is 67/100. The higher the solvency score, the more solvent the company is.
Score
Glenmark Pharmaceuticals Ltd's solvency score is 67/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
GLENMARK Price Targets Summary
Glenmark Pharmaceuticals Ltd
According to Wall Street analysts, the average 1-year price target for GLENMARK is 1 719.76 INR with a low forecast of 1 277.65 INR and a high forecast of 2 133.6 INR.
Dividends
Current shareholder yield for GLENMARK is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one GLENMARK stock under the Base Case scenario is 1 009.74 INR.
Compared to the current market price of 1 515.45 INR, Glenmark Pharmaceuticals Ltd is Overvalued by 33%.